OPUS GENETICS INC. - COMMON STOCK
1.1800
01-十一月-24 14:59:56
15 分钟延时
股票
-0.0200
-1.67%
今日范围
1.1600 - 1.2185
ISIN
N/A
来源
NASDAQ
-
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
30 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 11月 2023 15:38:14 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
27 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
13 11月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
02 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 11月 2023 15:52:46 条件 Nasdaq GlobeNewswire
-
01 11月 2023 07:05:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at AAO 2023 and Eyecelerator Retina Showcase
26 10月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
06 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
27 9月 2023 07:00:12 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Participate in Three Upcoming Investment Bank Conferences
11 9月 2023 08:41:55 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September
07 9月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposium
28 8月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
11 8月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
08 8月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
26 7月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 7月 2023 16:19:14 条件 Nasdaq GlobeNewswire
-
27 6月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
21 6月 2023 07:00:00 条件 Nasdaq GlobeNewswire